Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Classical hematology 2

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 88Leukemia, Myeloid, Acute 34Leukemia 32Myelodysplastic Syndromes 22Lymphoma, Follicular 18Lymphoma, Non-Hodgkin 16Lymphoma, B-Cell, Marginal Zone 16Lymphoma 16Lymphoma, Mantle-Cell 15Lymphoma, Large B-Cell, Diffuse 12Waldenstrom Macroglobulinemia 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Multiple Myeloma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia, Myelomonocytic, Chronic 9Burkitt Lymphoma 9Hematologic Neoplasms 8Recurrence 7Lymphoma, T-Cell, Peripheral 7Lymphoma, Large-Cell, Immunoblastic 7Leukemia, Plasma Cell 7Lymphoma, Large-Cell, Anaplastic 6Leukemia, B-Cell 6Immunoblastic Lymphadenopathy 6Hodgkin Disease 6Sezary Syndrome 5Mycosis Fungoides 5Leukemia, Hairy Cell 5Intraocular Lymphoma 5Anemia 5

Interventions

eltrombopag 9Platelet Transfusion 5Cytarabine 5Peripheral Blood Stem Cell Transplantation 3Daunorubicin 3fludarabine phosphate 2Tranexamic Acid 2Radiotherapy 2Lenalidomide 2Filgrastim 2Etoposide 2Cyclosporine 2Busulfan 2sargramostim 1oprelvekin 1ofatumumab 1leridistim 1bryostatin 1 1alvocidib 1Vitamin E 1Vincristine 1Transplantation 1Topotecan 1Thioguanine 1Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Prednisone 1Microarray Analysis 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Thrombocytopenia × Lenalidomide × Other hematologic neoplasm × Clear all
NCT01002755 2019-05-07

Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
36 enrolled 7 charts
Classical hematologyLymphoidOther hematologic neoplasm

Lymphadenopathy, Agammaglobulinemia, Fatigue, Fever, Lymphocytosis, Paraproteinemias, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00735930 2015-04-02

Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
39 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡